Yüklüyor......
Targeting glioma stem‐like cell survival and chemoresistance through inhibition of lysine‐specific histone demethylase KDM2B
Glioblastoma (GBM) ranks among the most lethal cancers, with current therapies offering only palliation. Inter‐ and intrapatient heterogeneity is a hallmark of GBM, with epigenetically distinct cancer stem‐like cells (CSCs) at the apex. Targeting GSCs remains a challenging task because of their uniq...
Kaydedildi:
| Yayımlandı: | Mol Oncol |
|---|---|
| Asıl Yazarlar: | , , , , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
John Wiley and Sons Inc.
2018
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5830623/ https://ncbi.nlm.nih.gov/pubmed/29360266 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/1878-0261.12174 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|